Summary:
Click image to enlargeFor patients with schizophrenia, strictly following prescribed antipsychotic medication is likely to bring better symptom control, reduced risk of relapse and rehospitalization, and improved quality of life as well as social and occupational functioning. Yet failing to adhere to their dose every day is one of the biggest reasons for relapse.
That is why our doctors our conducting a clinical trial evaluate an investigational one a month medication for schizophrenia.
If your medications are generally working, but you had a replase episode in the past 2 years, you may qualify for this study.
Qualified Participants Must:
• diagnosis of schizophrenia
•
antipsychotics have generally worked in the past year
•
have had an episode of relapse within the last 2 years
•
be 18 or older
Qualified Participants May Receive:
✔ Compensation may be available.
✔ All doctor’s exams, labs & medications cost covered. No insurance required.
✔ Help advance research into potential new medication options for schizophrenia.